Glucagon-Like Peptide-1 Receptor Agonist in ADPKD | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Glucagon-Like Peptide-1 Receptor Agonist in ADPKD	Abnormalities, Multiple, Body Weight, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, nutritional disorder, obesity disorder, overnutrition, polycystic kidney disease, urinary system disorder	Recruiting	Phase 2	2025-05-06		NCT06582875

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Mayo Clinic	970
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617
University of Colorado, Denver	475
Washington University School of Medicine	475

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Colorado - Anschutz Medical Campus	Aurora	United States	14